CAS 1151813-61-4

KSI-3716

CAS: 1151813-61-4

KSI-3716

Reinheit: ≥98%

Molekulargewicht: 426.09g/mol

Ref: 54-BUP21905

KSI-3716

CAS: 1151813-61-4

KSI-3716 is a potent inhibitor of kinases, which are enzymes that play a critical role in cancer cell growth and survival. This inhibitor has been shown to be effective against Chinese and human kinases, making it a promising candidate for the treatment of various types of cancer. KSI-3716 is an analog of oseltamivir, a drug used to treat influenza. It has been found to induce apoptosis in tumor cells by inhibiting the activity of protein kinases. KSI-3716 also shows anticancer activity in vivo, as demonstrated by its ability to inhibit tumor growth in mice models. This inhibitor may have potential therapeutic applications for the treatment of cancer and other diseases related to kinase dysregulation.

Formel: C₁₇H₁₁BrCl₂N₂O₂

Reinheit: Min. 95%

Molekulargewicht: 426.1 g/mol

Ref: 3D-BWB81361

KSI-3716

CAS: 1151813-61-4

KSI-3716 is a c-Myc inhibitor, a bladder chemotherapy agent that blocks the formation of complexes between c-MYC/MAX and target gene promoters.

Formel: C₁₇H₁₁BrCl₂N₂O₂

Reinheit: 98.94%

Farbe und Form: Solid

Molekulargewicht: 426.09

Ref: TM-T11783